10190-7 |
Mental status |
Find |
^Patient |
Pt |
Nar |
Observed |
|
ACTIVE |
Mental status Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10190-7 |
|
Observed |
|
|
|
|
|
|
0 |
Mental status |
|
|
|
|
|
Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report |
2.58 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101900-9 |
Action plan |
Find |
{Setting} |
Pt |
Doc |
Geriatric medicine |
|
ACTIVE |
Geriatric medicine Action plan |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
101900-9 |
|
Geriatric medicine |
|
|
|
|
|
|
0 |
Geri med |
|
|
|
N |
|
DOC.ONT; Document; Finding; Findings; Geri med; Gerontology; Point in time; Random |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101901-7 |
Action plan |
Find |
{Setting} |
Pt |
Doc |
Mental health |
|
ACTIVE |
Mental health Action plan |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
101901-7 |
|
Mental health |
|
|
|
|
|
|
0 |
Mental health |
|
|
|
N |
|
DOC.ONT; Document; Emotional stability; Finding; Findings; Point in time; Random |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101902-5 |
little c Ag |
PrThr |
RBC^Fetus |
Pt |
Ord |
|
|
ACTIVE |
little c Ag [Presence] on Red Blood Cells from Fetus |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
101902-5 |
|
|
|
|
Both |
|
|
|
0 |
little c Ag RBC Fetus Ql |
|
|
|
N |
|
Antigen; Antigens; BLOOD BANK; c; Erythrocytes; Fetal; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101903-3 |
K Ag |
PrThr |
RBC^Fetus |
Pt |
Ord |
|
|
ACTIVE |
K Ag [Presence] on Red Blood Cells from Fetus |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
101903-3 |
|
|
|
|
Both |
|
|
|
0 |
K Ag RBC Fetus Ql |
|
|
|
N |
|
Antigen; Antigens; BLOOD BANK; Erythrocytes; Fetal; KEL1; Kell Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101904-1 |
Release of Information request |
Find |
{Setting} |
Pt |
Doc |
|
|
ACTIVE |
Release of Information request |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
101904-1 |
|
|
|
|
|
|
|
|
0 |
ROI request |
|
|
|
N |
|
DOC.ONT; Document; Finding; Findings; Point in time; Random; ROI request |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101905-8 |
Follitropin & lutropin post leuprolide stimulation panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Follitropin and lutropin post leuprolide stimulation panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
101905-8 |
|
|
|
|
Order |
|
|
|
0 |
FSH+LH p leuprolide stm Pnl Ser |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; FSH+LH p leuprolide stm Pnl; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leuprorelin; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; PST; Random; Serum; SR; Stim |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
101906-6 |
Noninvasive esophageal cancer DNA+esophageal cell screening |
PrThr |
Esophagus |
Pt |
Ord |
Sequencing |
|
ACTIVE |
Noninvasive esophageal cancer DNA and esophageal cell screening [Presence] in Esophagus by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
101906-6 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
Noninv esophageal Ca screen Esoph Ql Seq |
|
|
|
N |
|
Asympt; Asymptomatic; Deoxyribonucleic acid; Esophageal; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Next generation sequencing; NGS; Noninv esophageal Ca screen; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Screen |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101907-4 |
Adaptor Protein 3 Beta2 Ab.IgG |
PrThr |
XXX |
Pt |
Ord |
|
|
ACTIVE |
AP-3 complex IgG Ab [Presence] in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101907-4 |
|
|
|
|
Both |
|
|
|
0 |
AP3B2 IgG Spec Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; AP3B2; AP3B2 Ab; AP3B2 IgG; Autoantibodies; Autoantibody; III; Immune globulin G; Immunoglobulin G; Misc; Miscellaneous; NAPTB; Ordinal; Other; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spec; To be specified in another part of the message; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101908-2 |
Adaptor Protein 3 Beta2 Ab |
Titr |
XXX |
Pt |
SemiQn |
|
|
ACTIVE |
AP-3 complex Ab [Titer] in Specimen |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
101908-2 |
|
|
|
|
Both |
|
|
|
0 |
AP3B2 Ab Titr Spec |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; AP3B2; AP3B2 Ab; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); III; Misc; Miscellaneous; NAPTB; Other; Point in time; PR; Prot; Random; Serology; SmQn; Spec; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
101909-0 |
Protein monoclonal panel |
- |
Urine |
Pt |
- |
|
|
ACTIVE |
Protein monoclonal panel - Urine |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
101909-0 |
|
|
|
|
Order |
|
|
|
0 |
Protein mono pnl Ur |
|
|
|
N |
|
Chemistry; M Protein; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Pan; PANEL.CHEMISTRY; Panl; Para protein; Paraprotein; Pnl; Point in time; PR; Prot; Protein mono pnl; Random; UA; UR; Urn |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
10191-5 |
Physical findings |
Find |
Abdomen |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Abdomen Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10191-5 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Abd |
|
|
|
|
|
Abd; Abdo; Abdomen+; Abdominal; Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101910-8 |
Protein monoclonal panel 24Hr |
- |
Urine |
24H |
- |
|
|
ACTIVE |
Protein monoclonal panel 24Hr Urine |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
101910-8 |
|
|
|
|
Order |
|
|
|
0 |
Protein mono pnl 24 Hr Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; M Protein; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Pan; PANEL.CHEMISTRY; Panl; Para protein; Paraprotein; Pnl; PR; Pro mono 24Hr; Prot; Protein mono pnl; UA; UR; Urn |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
101911-6 |
Troponin T. cardiac 2 Hr 5th generation |
MCnc |
Ser/Plas |
2H |
Qn |
|
|
ACTIVE |
Troponin T. cardiac [Mass/volume] in 2 hour 5th generation Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/L |
|
|
|
|
|
|
CHEM |
|
101911-6 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T 2h 5th gen SerPl-MCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; cTnT; II; Level; Mass concentration; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin |
2.75 |
2.75 |
|
|
|
|
|
|
|
ng/L |
|
|
|
0 |
101912-4 |
Troponin T.cardiac delta |
MCncDiff |
Ser/Plas |
2H |
Qn |
|
|
ACTIVE |
Troponin T.cardiac delta [Mass concentration difference] in 2 hour Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
ng/L |
|
|
|
|
|
|
CHEM |
|
101912-4 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T. D 2h SerPl-MCDiff |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; cTnT; MCDiff; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; Troponin T. D |
2.76 |
2.75 |
|
|
|
|
|
|
|
ng/L |
|
|
|
0 |
101913-2 |
Troponin T.cardiac delta/Troponin T.cardiac^baseline |
AFr |
Ser/Plas |
2H |
Qn |
|
|
ACTIVE |
Troponin T.cardiac delta/Troponin T.cardiac in 2 hour Serum or Plasma --baseline |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
101913-2 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T. D/Troponin T BS 2h % SerPl |
|
|
|
N |
|
%; 120 min; 120 minutes; 120min; 2 hours; 2HR; BS; Chemistry; cTnT; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; Troponin T. D |
2.76 |
2.75 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
101914-0 |
Troponin T.cardiac delta |
Imp |
Ser/Plas |
2H |
Ord |
|
|
ACTIVE |
Troponin T.cardiac delta [Interpretation] in 2 hour Serum or Plasma Qualitative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
101914-0 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T. D 2h SerPl-Imp |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; cTnT; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Pl; Plasma; Plsm; QL; Qual; Qualitative; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; Troponin T. D |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101915-7 |
Troponin T.cardiac |
MCnc |
Ser/Plas |
6H |
Qn |
|
|
ACTIVE |
Troponin T.cardiac [Mass/volume] in 6 hour Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/L |
|
|
|
|
|
|
CHEM |
|
101915-7 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T 6h SerPl-mCnc |
|
|
|
N |
|
6 hours; 6Hr; Chemistry; cTnT; Level; Mass concentration; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin |
2.75 |
2.75 |
|
|
|
|
|
|
|
ng/L |
|
|
|
0 |
101916-5 |
Troponin T.cardiac delta |
MCncDiff |
Ser/Plas |
6H |
Qn |
|
|
ACTIVE |
Troponin T.cardiac delta [Mass concentration difference] in 6 hour Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
ng/L |
|
|
|
|
|
|
CHEM |
|
101916-5 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T. D 6h SerPl-MCDiff |
|
|
|
N |
|
6 hours; 6Hr; Chemistry; cTnT; MCDiff; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; Troponin T. D |
2.76 |
2.75 |
|
|
|
|
|
|
|
ng/L |
|
|
|
0 |
101917-3 |
Troponin T.cardiac delta/Troponin T.cardiac^baseline |
AFr |
Ser/Plas |
6H |
Qn |
|
|
ACTIVE |
Troponin T.cardiac delta/Troponin T.cardiac in 6 hour Serum or Plasma --baseline |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
101917-3 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T. D/Troponin T BS 6h % SerPl |
|
|
|
N |
|
%; 6 hours; 6Hr; BS; Chemistry; cTnT; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; Troponin T. D |
2.76 |
2.75 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
101918-1 |
Troponin T.cardiac delta |
Imp |
Ser/Plas |
6H |
Ord |
|
|
ACTIVE |
Troponin T.cardiac delta [Interpretation] in 6 hour Serum or Plasma Qualitative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
101918-1 |
|
|
|
|
Both |
|
|
|
0 |
Troponin T. D 6h SerPl-Imp |
|
|
|
N |
|
6 hours; 6Hr; Chemistry; cTnT; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Pl; Plasma; Plsm; QL; Qual; Qualitative; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; Troponin T. D |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101919-9 |
Iohexol disappearance panel |
- |
Urine+Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Iohexol disappearance panel - Urine and Serum or Plasma |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
101919-9 |
|
|
|
|
Order |
|
|
|
0 |
Iohexol dis pnl Ur+SerPl |
|
|
|
N |
|
Chemistry; Iohexol dis pnl; Iohexol dp; Omnipaque; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn |
2.77 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Removed plasma from the panel code, the children have multiple options for system Urine, Serum/Plasma; COMPONENT: removed plasma from the component; |
0 |
10192-3 |
Physical findings |
Find |
Back |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Back Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10192-3 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Back |
|
|
|
|
|
Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101920-7 |
Chronic lymphocytic leukemia gene targeted rearrangements |
Find |
Bld/Bone mar |
Pt |
Doc |
FISH |
|
ACTIVE |
Chronic lymphocytic leukemia gene targeted rearrangements in Blood or Marrow by FISH |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.REARRANGE |
|
101920-7 |
|
FISH |
|
|
Both |
|
|
|
0 |
CLL gene targeted rearrange Bld/Mar FISH |
|
|
|
N |
|
B-cell CLL; Bld/Mar; Blood; BM; BON; Bone marrow; CLL; CLL gene; CLL gene targeted rearrange; Document; Finding; Findings; Fluorescent in situ hybridization; Lymphoma 1; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Point in time; Random; Rearr; Rearrangement; WB; Whole blood; Whole blood or Bone marrow |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101921-5 |
Iohexol renal clearance |
ArVRat |
Ser/Plas/Urine |
Pt |
Qn |
|
|
ACTIVE |
Iohexol renal clearance in Serum or Plasma or Urine |
|
ADD |
DefinitionDescription |
|
|
mL/min/1.73 sq m |
|
|
|
|
|
|
DRUG/TOX |
|
101921-5 |
|
|
|
|
Observation |
|
|
|
0 |
Iohexol Cl Ser/Plas/Urn-ArVRat |
|
|
|
N |
|
Cl; Clear; Clearanc; Clearances; Clr; DRUG/TOXICOLOGY; Drugs; Kidney; Omnipaque; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser/Plas/Urn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Urn; Volume rate/area; Volume Rate/Ratio |
2.75 |
2.75 |
|
|
|
|
|
|
|
mL/min/{1.73_m2} |
|
|
|
0 |